Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.79
(-1.56%)
CNY 3.79
(-1.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 984.13 Million | 663.63 Million | 524.29 Million | 406.02 Million | 394.15 Million | 27.26 Million |
| Net Income | -3.65 Billion | -1.22 Billion | -1.85 Billion | 993.6 Million | 100.35 Million | 10.24 Million |
| Depreciation & Amortization | 1.32 Billion | 1.28 Billion | 1.04 Billion | 327.21 Million | 155.43 Million | 105.05 Million |
| Deferred income taxes | 66.17 Million | -103.26 Million | -133.55 Thousand | -46.19 Million | -35.18 Million | -6.06 Million |
| Stock-based compensation | -4.39 Million | 19.24 Million | 9.89 Million | 42.04 Million | 7.31 Million | 10.35 Million |
| Change in working capital | 1.81 Billion | -577.2 Million | 203.4 Million | -1.31 Billion | -39.92 Million | -224.48 Million |
| Other non-cash items | 2.32 Billion | 1.26 Billion | 1.11 Billion | 408.79 Million | 206.16 Million | 136.44 Million |
| Investing Cash Flow | -274.92 Million | -1.7 Billion | -2.8 Billion | -4 Billion | -727.15 Million | -547.04 Million |
| Investments in PPE | -511.77 Million | -1.49 Billion | -2.7 Billion | -3.29 Billion | -658.44 Million | -569.15 Million |
| Acquisitions | 320.75 Million | -61.76 Million | -63.35 Million | -468.25 Million | -33.6 Million | -9.17 Million |
| Investment purchases | -1.67 Million | -107.53 Million | -19.75 Million | -167.78 Million | -24.2 Million | -55.33 Million |
| Sales/Maturities of investments | 5.45 Million | 9.12 Million | 1.03 Million | 4.29 Million | 234 Thousand | 101.14 Million |
| Other Investing Activities | -87.68 Million | -44.09 Million | -15.67 Million | -77.92 Million | -11.14 Million | -14.51 Million |
| Financing Cash Flow | -1.17 Billion | 1.22 Billion | 2.19 Billion | 3.92 Billion | 403.6 Million | 461.35 Million |
| Debt repayment | -204.03 Million | -5.22 Billion | -3.5 Billion | -1.91 Billion | -1.17 Billion | -521.11 Million |
| Dividends payments | -331.26 Million | -373.66 Million | -102.82 Million | -51.78 Million | -10.85 Million | -73.67 Million |
| Common Stock Repurchased | -8.44 Million | -61.82 Million | -3.11 Million | -12.36 Million | -11.5 Million | -712.11 Thousand |
| Common Stock Issuance | - | 61.82 Million | 3.11 Million | 12.36 Million | 11.5 Million | - |
| Other Financing Activities | -973.58 Million | 6.76 Billion | 6.05 Billion | 6.02 Billion | 1.66 Billion | 1.05 Billion |
| Accounts receivables | -301.32 Million | -47.36 Million | -146.69 Million | -325.2 Million | -64.04 Million | -189.51 Million |
| Accounts payables | -15.19 Million | 796.91 Million | 1.63 Billion | 501.37 Million | 316.57 Million | 35.73 Million |
| Inventory | 2.07 Billion | -1.22 Billion | -1.28 Billion | -1.44 Billion | -257.26 Million | -64.63 Million |
| Other working capital | 55.74 Million | -103.26 Million | -133.55 Thousand | -46.19 Million | -35.18 Million | -159.84 Million |
| Cash at beginning of period | 719.07 Million | 443.96 Million | 526.5 Million | 198.02 Million | 127.27 Million | 185.7 Million |
| Cash at end of period | 207.66 Million | 622.5 Million | 443.96 Million | 526.5 Million | 198.02 Million | 127.27 Million |
| Capital Expenditure | -511.77 Million | -1.49 Billion | -2.7 Billion | -3.29 Billion | -658.44 Million | -569.15 Million |
| Effect of forex changes on cash | -2.05 Million | -2.05 Million | -114.87 Thousand | -225.54 Thousand | 141.13 Thousand | 1765.89 |
| Net cash flow / Change in cash | -511.41 Million | 178.54 Million | -82.54 Million | 328.47 Million | 70.74 Million | -58.42 Million |
| Free Cash Flow | 472.36 Million | -835.3 Million | -2.18 Billion | -2.88 Billion | -264.28 Million | -541.89 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -278.98 Million | -247.98 Million | -292.01 Million | -2.36 Billion | -3.65 Billion | -480.56 Million |
| Depreciation & Amortization | - | 246.06 Million | 246.06 Million | 312.96 Million | 1.32 Billion | -661.97 Million |
| Deferred income taxes | - | - | - | - | 66.17 Million | 808.35 Million |
| Stock-based compensation | - | - | - | -4.39 Million | -4.39 Million | -7.47 Million |
| Change in working capital | - | 378.77 Million | - | 1.82 Billion | 1.81 Billion | -155.5 Million |
| Other non-cash items | 249.8 Million | 707.34 Million | 263.53 Million | 2.99 Billion | 2.32 Billion | 797.23 Million |
| Investing Cash Flow | -55.58 Million | -25.03 Million | 91.01 Million | 73.37 Million | -274.92 Million | -77.3 Million |
| Investments in PPE | -57.83 Million | -37.17 Million | -137.62 Million | -95.18 Million | -511.77 Million | -90.37 Million |
| Acquisitions | 4.55 Million | 20.87 Million | 182.3 Million | 170.97 Million | 320.75 Million | 5.89 Million |
| Investment purchases | 1.32 Million | -1.32 Million | - | -1.67 Million | -1.67 Million | 2.26 Million |
| Sales/Maturities of investments | -4.56 Million | -14.84 Million | 43.04 Million | 838.14 Thousand | 5.45 Million | 1 Million |
| Other Investing Activities | 931.9 Thousand | -289.99 Thousand | 3.28 Million | -1.56 Million | -87.68 Million | 3.9 Million |
| Financing Cash Flow | 45.63 Million | 39.39 Million | -70.39 Million | -440.25 Million | -1.17 Billion | -284.34 Million |
| Debt repayment | -236.1 Million | -102.48 Million | -12.52 Million | -219.39 Million | -204.03 Million | -1.74 Billion |
| Dividends payments | - | -17.03 Million | -29.02 Million | -98.86 Million | -331.26 Million | -77.85 Million |
| Common Stock Repurchased | - | -2.14 Million | - | -8.44 Million | -8.44 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 281.73 Million | 159.89 Million | -57.87 Million | -220.85 Million | -973.58 Million | 1.53 Billion |
| Accounts receivables | - | -107.54 Million | - | -301.32 Million | -301.32 Million | 302.32 Million |
| Accounts payables | - | - | - | - | -15.19 Million | - |
| Inventory | - | 477.32 Million | - | 2.07 Billion | 2.07 Billion | -457.82 Million |
| Other working capital | - | 8.99 Million | - | 55.74 Million | 55.74 Million | -26.51 Million |
| Cash at beginning of period | 427.79 Million | 144.18 Million | 207.66 Million | 299.51 Million | 719.07 Million | 259.76 Million |
| Cash at end of period | 378.55 Million | 375.03 Million | 206.97 Million | 207.66 Million | 207.66 Million | 197.08 Million |
| Capital Expenditure | -57.83 Million | -37.17 Million | -137.62 Million | -95.18 Million | -511.77 Million | -90.37 Million |
| Effect of forex changes on cash | - | -16.99 Thousand | 6897.36 | -835.82 Thousand | -2.05 Million | -1.1 Million |
| Net cash flow / Change in cash | -49.23 Million | 230.84 Million | -689.81 Thousand | -91.85 Million | -511.41 Million | -62.68 Million |
| Free Cash Flow | -87.01 Million | 176.12 Million | -166.11 Million | 227.49 Million | 472.36 Million | 209.69 Million |
1572
DORM
PENTA
HOCL
ABTZY
0973